Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    Marlene Busko 

    News

    SGLT2 inhibitors: Real-world data show benefits outweigh risks

    Author:
    Marlene Busko 
    Publish date: April 3, 2023

    “The importance of our paper is that it quantifies the absolute rate of events among routine care patients and may be used to inform shared...

    • Read More

    News

    Longer life after bariatric surgery, but suicide risk in young

    Author:
    Marlene Busko 
    Publish date: February 8, 2023

    Death from diabetes was 72% lower in the bariatric surgery patients versus nonsurgery peers.

    • Read More

    News

    Persistent gaps in drug use by patients with type 2 diabetes

    Author:
    Marlene Busko 
    Publish date: February 7, 2023

    Continuous use of glucose-, BP-, and cholesterol-lowering medications by adults with mainly type 2 diabetes declined in 2005-2019. This may...

    • Read More

    News

    More type 2 diabetes deaths from cancer than heart disease

    Author:
    Marlene Busko 
    Publish date: January 27, 2023

    In people with type 2 diabetes, cancer screening should get at least as much attention as CVD prevention.

    • Read More

    News

    New osteoporosis guideline says start with a bisphosphonate

    Author:
    Marlene Busko 
    Publish date: January 4, 2023

    Initial therapy with bisphosphonates for postmenopausal women with osteoporosis and men with osteoporosis are strongly recommended.

    • Read More

    News

    Rosuvastatin again linked with risks to kidneys

    Author:
    Marlene Busko 
    Publish date: July 22, 2022

    Practice should more often heed FDA-recommended rosuvastatin dosages for patients with severe chronic kidney disease and step up monitoring for...

    • Read More

    News

    Jury still out on cardiovascular safety of testosterone

    Author:
    Marlene Busko 
    Publish date: June 10, 2022

    A meta-analysis may provide some reassurance of the short-term cardiovascular safety of testosterone therapy for male hypogonadism until...

    • Read More

    News

    ADA updates on finerenone, SGLT2 inhibitors, and race-based eGFR

    Author:
    Marlene Busko 
    Publish date: June 9, 2022

    ADA has made an interim change to its latest Standards of Medical Care, an update based on trial evidence and consensus about finerenone, SGLT2...

    • Read More

    News

    Experts endorse plant-based diet for type 2 diabetes remission

    Author:
    Marlene Busko 
    Publish date: May 25, 2022

    As a primary intervention, diet can achieve type 2 diabetes remission in many adults with normal or elevated BMI, and should be a plant-based,...

    • Read More

    News

    Could new therapy for food ‘cues’ improve weight loss?

    Author:
    Marlene Busko 
    Publish date: May 19, 2022

    Patients highly sensitive to food ‘cues’ may benefit from behavioral therapy, but the intervention is labor intensive and tied to modest weight...

    • Read More

    News

    Grit your teeth for a lesser-known complication of diabetes

    Author:
    Marlene Busko 
    Publish date: May 12, 2022

    Tooth loss is a lesser-known potential complication of type 2 diabetes. A large meta-analysis quantifies the risk.

    • Read More

    News

    Artificial sweeteners: A modifiable cancer risk?

    Author:
    Marlene Busko 
    Publish date: March 25, 2022

    “Our findings do not support the use of artificial sweeteners as safe alternatives for sugar in foods or beverages,” said the researchers. An...

    • Read More

    News

    Lights on during sleep can play havoc with metabolism

    Author:
    Marlene Busko 
    Publish date: March 15, 2022

    If a light is needed for safety reasons, keep it as dim as possible and avoid exposure to blue or green light, but instead try red-amber colors....

    • Read More

    News

    Heavy cannabis use tied to less diabetes in women

    Author:
    Marlene Busko 
    Publish date: February 10, 2022

    Women, but not men, who used marijuana at least four times in the previous month were less likely to have type 2 diabetes than nonusers, found a...

    • Read More

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery